ADVANCED/METASTATIC SOLID TUMORS
Clinical trials for ADVANCED/METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug candidate targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests an experimental drug called FDA018-ADC in people with advanced solid tumors (like breast, lung, or bladder cancer) who have run out of standard options. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. About…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New antibody drug targets immune system to fight advanced cancers
Disease control OngoingThis early-phase study tests a new drug called ADG206 in people with advanced solid tumors that have not responded to standard treatments. ADG206 is designed to activate the immune system to attack cancer cells. The main goals are to check safety, find the right dose, and see how…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Adagene Inc • Aim: Disease control
Last updated May 11, 2026 20:47 UTC